AHR and hepatocellular carcinoma: For example, while the AhR agonist indirubin (IR) has been shown to have a 10-fold greater potency as an inducer of AhR-dependent gene expression than TCDD in human hepatoma cells, it is ~10-fold less potent than TCDD in mouse hepatoma cells [23].